Predictively consistent prior effective sample sizes
- PMID: 32142163
- DOI: 10.1111/biom.13252
Predictively consistent prior effective sample sizes
Abstract
Determining the sample size of an experiment can be challenging, even more so when incorporating external information via a prior distribution. Such information is increasingly used to reduce the size of the control group in randomized clinical trials. Knowing the amount of prior information, expressed as an equivalent prior effective sample size (ESS), clearly facilitates trial designs. Various methods to obtain a prior's ESS have been proposed recently. They have been justified by the fact that they give the standard ESS for one-parameter exponential families. However, despite being based on similar information-based metrics, they may lead to surprisingly different ESS for nonconjugate settings, which complicates many designs with prior information. We show that current methods fail a basic predictive consistency criterion, which requires the expected posterior-predictive ESS for a sample of size N to be the sum of the prior ESS and N. The expected local-information-ratio ESS is introduced and shown to be predictively consistent. It corrects the ESS of current methods, as shown for normally distributed data with a heavy-tailed Student-t prior and exponential data with a generalized Gamma prior. Finally, two applications are discussed: the prior ESS for the control group derived from historical data and the posterior ESS for hierarchical subgroup analyses.
Keywords: Fisher information; co-data; historical data; meta-analytic-predictive prior distribution; prior predictive distribution.
© 2020 The International Biometric Society.
Comment in
-
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.Biometrics. 2020 Jun;76(2):591-594. doi: 10.1111/biom.13247. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251521
-
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.Biometrics. 2020 Jun;76(2):595-598. doi: 10.1111/biom.13246. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251522 No abstract available.
-
Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.Biometrics. 2020 Jun;76(2):602-605. doi: 10.1111/biom.13245. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251524 No abstract available.
-
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.Biometrics. 2020 Jun;76(2):599-601. doi: 10.1111/biom.13254. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251527 Free PMC article.
-
Discussion on "Predictively Consistent Prior Effective Sample Sizes" by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.Biometrics. 2020 Jun;76(2):588-590. doi: 10.1111/biom.13253. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251530 No abstract available.
References
REFERENCES
-
- 21st Century Cures Act. (2015) A bill to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes. Available at: http://docs.house.gov/meetings/IF/IF00/20150519/103516/BILLS-1146ih.pdf. [Accessed 17 March 2020].
-
- Baeten, D., Baraliakos, X., Braun, J., Sieper, J., Emery, P., van der Heijde, D., McInnes, I., van Laar, J., Landewe, R., Wordsworth, P., Wollenhaupt, J., Kellner, H., Paramarta, J., Wei, J., Brachat, A., Bek, S., Laurent, D., Li, Y., Wang, Y., Bertolino, A., Gsteiger, S., Wright, A.M. and Hueber, W. (2013) Anti-interleukin-17A monoclonal antibody secukinumab in ankylosing spondylitis: a randomized, double-blind, placebo-controlled trial. The Lancet, 382, 1705-1713.
-
- Chen, M.H. and Ibrahim, J.G. (2000) Power prior distributions for regression models. Statistical Science, 15(1), 46-60.
-
- Chugh, R., Wathen, K., Maki, R., Benjamin, R., Patel, R., Myers, P., Priebat, D., Reinke, D., Thomas, D., Keohan, M., Samuels, B. and Baker, L. (2009) Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a Bayesian hierarchical statistical model. Journal of Clinical Oncology, 27(19), 3148-3153.
-
- Dallal, S. and Hall, W. (1983) Approximating priors by mixtures of natural conjugate priors. Journal of the Royal Statistical Society Series B, 45, 278-286.
MeSH terms
LinkOut - more resources
Full Text Sources